# Exploratory Clinical Study of CNCT19 Anti CD19 Cell Therapy in the Treatment of Refractory Autoimmune Diseases

> **NCT06316791** · EARLY_PHASE1 · RECRUITING · sponsor: **Juventas Cell Therapy Ltd.** · enrollment: 24 (estimated)

## Conditions studied

- Lupus Erythematosus, Systemic

## Interventions

- **BIOLOGICAL:** single dose of CNCT19

## Key facts

- **NCT ID:** NCT06316791
- **Lead sponsor:** Juventas Cell Therapy Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-14
- **Primary completion:** 2025-12-13
- **Final completion:** 2025-12-13
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06316791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06316791, "Exploratory Clinical Study of CNCT19 Anti CD19 Cell Therapy in the Treatment of Refractory Autoimmune Diseases". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06316791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*